Qualify for free participation and up to $144 per visit (including transportation reimbursement)
Are you looking for places?
Or looking for places to go?
Managing your benign prostatic hyperplasia (BPH) alone may not be enough.
If you are a man on BPH therapy for an enlarged prostate and visiting the bathroom frequently, you may have an overactive bladder (OAB).
The immediate need to ‘go’ interrupts your day and night – and it may not be caused by your BPH.
If these symptoms disrupt your day and night, you may also have a condition called overactive bladder (OAB).
About the COURAGE Study
A clinical research study is testing the safety and effectiveness of an investigational drug in men on BPH therapy experiencing OAB symptoms. The investigational drug, vibegron, is compared with a placebo. A placebo looks exactly like the investigational drug but contains no active medication. Over 1000 participants in approximately 135 study centers across North America and Europe are expected to take part in the COURAGE Study.
Click here to view the study (NCT03902080) on clinicaltrials.gov
Can I take part?
To determine whether you are eligible to take part in the COURAGE Study, you will be invited to visit a study center to undergo medical tests and assessments. If eligible, you will be asked to attend 10 more visits to undergo further tests: 8 visits will take place at the study center and 2 visits via video/telephone call. You will be asked to take either the investigational drug or placebo every day for 26 weeks.
What happens at the end of the study?
To determine whether you are eligible to take part in the COURAGE Study, you will be invited to visit a study center to undergo medical tests and assessments. If eligible, you will be asked to attend 10 more visits to undergo further tests: 8 visits will take place at the study center and 2 visits via video/telephone call. You will be asked to take either the investigational drug or placebo every day for 26 weeks.